Truist Financial’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-183,180
Closed -$2.82M 2698
2024
Q2
$2.82M Buy
183,180
+84,251
+85% +$1.2M ﹤0.01% 1115
2024
Q1
$1.46M Buy
+98,929
New +$1.37M ﹤0.01% 1437
2023
Q1
Sell
-61,577
Closed -$765K 2663
2022
Q4
$765K Buy
+61,577
New +$785K ﹤0.01% 1686
2021
Q4
Sell
-12,110
Closed -$178K 2839
2021
Q3
$178K Buy
+12,110
New +$205K ﹤0.01% 2584
2021
Q1
Sell
-47,673
Closed -$828K 2719
2020
Q4
$828K Buy
47,673
+157
+0.3% +$2.5K ﹤0.01% 1578
2020
Q3
$655K Sell
47,516
-3,333
-7% -$49K ﹤0.01% 1587
2020
Q2
$734K Buy
50,849
+12
+0% +$158 ﹤0.01% 1425
2020
Q1
$555K Sell
50,837
-5,256
-9% -$96.9K ﹤0.01% 1515
2019
Q4
$1.2M Buy
+56,093
New +$1.26M ﹤0.01% 1366

Other funds holding SBRA

Truist Financial's SBRA Position: Q3 2024 in Review

Truist Financial sold out of Sabra Healthcare REIT (SBRA) in Q3 2024, closing a stake of 183,180 shares — an estimated $2.82M sold.

Truist Financial first reported a position in SBRA in Q4 2019 and held it in 9 quarters. The position peaked at $2.82M in Q2 2024. 379 funds tracked by Wall St. Rank hold SBRA as of Q3 2024.

  • Truist Financial reported no remaining Sabra Healthcare REIT position as of Q3 2024 after selling out during the quarter.
  • Truist Financial sold 183,180 Sabra Healthcare REIT shares in Q3 2024, an estimated $2.82M.
  • Truist Financial first reported a position in Sabra Healthcare REIT in Q4 2019 and held it in 9 quarters.
  • Truist Financial's Sabra Healthcare REIT position peaked at $2.82M in Q2 2024.
  • 379 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2024.

Based on Truist Financial's 13F filing for Q3 2024, filed 13 Nov 2024.